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Abstract
Background: Intronic DNA sequences of the canine arrestin (SAG) gene was screened to identify
potential disease causing mutations in dogs with generalized progressive retinal atrophy (gPRA).
The intronic sequences flanking each of the 16 exons were obtained from clones of a canine
genomic library.
Results: Using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP)
and DNA sequence analyses we screened affected and unaffected dogs of 23 breeds with presumed
autosomal recessively (ar) transmitted gPRA. In the coding region of the SAG gene 12 nucleotide
exchanges were identified, 5 of which lead to amino acid substitutions (H14C; A111V; A113T;
D259T; A379E). 7 other exonic substitutions represent silent polymorphisms (C132C; Q199Q;
H225H; V247V; P264P; T288T and L293L). 16 additional sequence variations were observed in
intronic regions of different dog breeds.
Conclusions:  In several breeds, these polymorphisms were found in homozygous state in
unaffected and in heterozygous state in affected animals. Consequently these informative
substitutions provide evidence to exclude mutations in the SAG gene as causing retinal
degeneration in 14 of the 23 dog breeds with presumed ar transmitted gPRA.
Background
gPRA is usually inherited as an ar blinding disorder with
different ages of onset and variable rate of progression ob-
served in more than 100 dog breeds. Typically, gPRA com-
mences with degeneration of the rod photoreceptors.
Initial signs include night blindness whereas progression
involves the cones and the central vision [1,2]. The hu-
man equivalent of canine gPRA is termed retinitis pig-
mentosa (RP). RP comprises a large and genetically
heterogeneous group of blinding disorders. RP may be in-
herited in an ar, dominant, X-linked, digenic or maternal
mode [3–7]. Similarly in dogs, at least 4 genes were iden-
tified so far as causing gPRA in 6 breeds. All of these genes
encode photoreceptor specific proteins involved in the
visual transduction cascade including the β -subunit of the
cGMP-specific phosphodiesterase (PDE6B) in Irish Setters
and Sloughis [8,9] as well as the α -subunit of the cGMP-
specific phosphodiesterase (PDE6A) in Cardigan Welsh
Corgis [10]. A missense mutation was detected in the PDC
gene that may be associated with photoreceptor dysplasia,
a form of gPRA in the Miniature Schnauzer [11]. The X-
linked form of PRA in Samoyed and Siberian Husky is
caused by mutations in the RPGR gene [12]. Recently in
English Mastiff dogs an autosomal dominantly transmit-
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ted form of gPRA was identified, mimicking human RP.
The disease causing mutation is a T4R exchange in the rho-
dopsin (RHO) gene [13]. A number of other retinal genes
have been excluded as harbouring mutations for gPRA in
several dog breeds: RHO; [14], RDS/peripherin and ROM-
1 [15] as well as the α  – and γ -subunits of transducin[16]
and SAG[17]. Yet, the SAG gene had been analyzed on the
exonic level exclusively, i.e. by sequencing of cDNA. The
human SAG gene comprises 16 exons ranging in size be-
tween 243 and 10 bp. SAG protein (403 amino acids) has
been identified only in retinal photoreceptor rods and
pinealocytes [18].
Table 1: Characteristics of dog breeds examined
Breed (abbreviation) Number of dogs Diagnosis Onset forms of gPRA Age distribution 
(year)f
Afghan Hound (AW) 1 gPRA-affected lateb 6
4 normal 2–12
Australian Cattle dogs (AC) 2 gPRA-affected latea 10
19 normal 2–4
Berger des Pyrénées (BDP) 1 gPRA-affected mid-onsetb 5
42 normal 1–10
Berner Sennenhund (BS) 1 gPRA-affected lateb 10
Bolognese (Bo) 1 gPRA-affected lateb 9
Collie (Co) 3 gPRA-affected earlycd 4–8
1n o r m a l 8
Curly Coated Retriever (CCR) 1 gPRA-affected lateb 6
Dachshund (wire; D) 20 gPRA-affected variableb 1–13
49 normal 6–13
Engl. Cocker Spaniel (ECS) 6 gPRA-affected latecd 3–11
6 normal 6–14
English Springer Spaniel (SP) 1 gPRA-affected 7
Entlebucher Mountain Dog (EM) 17 gPRA-affected latee 5–13
10 normal 1–7
Giant Schnauzer (GS) 1 gPRA-affected lateb 10
Golden Retriever (GR) 2 gPRA-affected lateb 5–10
8 normal 3–6
Irish Setter (IRS) 2 gPRA-affected earlycd/lateb 0.6–7
1 normal 3–13
Labrador Retriever (LR) 5 gPRA-affected latecd 8–12
140 normal 3–13
Miniature poodle (MP) 28 gPRA-affected latecd 5–12
15 normal 1–12
Newfoundland Dog (NF) 1 gPRA-affected mid-onsetb 3
Polski Owczarek Nizinny (PON) 1 gPRA-affected lateb 9
Rottweiler (Ro) 1 gPRA-affected lateb 3
Saarloos/Wolfhond (Sa) 7 gPRA-affected lateb 7–9
118 normal 2–10
Schapendoes (SD) 3 gPRA-affected earlyd 2–6
7 normal 3–6
Sloughi (Sl) 5 gPRA-affected mid-onsetb 2
183 normal 0.1–12
Tibetan Terrier (TT) 3 gPRA-affected mid-onsetcd 7–8
93 normal 2–10
a[34]. b owners report/certificate of eye examination. c classifications of the different onset forms of gPRA in the reviews [1] and [2]. d online infor-
mation among PRA Today  [http://www.sheepdog.com/diseases/pra/clinical]. e[35]. f at the time when blood was taken for DNA analysis.BMC Genetics 2002, 3 http://www.biomedcentral.com/1471-2156/3/12
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SAG belongs to a family of inhibitory proteins that bind
to tyrosine-phosphorylated receptors, thereby blocking
their interaction with G-proteins and effectively terminat-
ing the signalling chain. In the phototransduction cas-
cade, SAG and rhodopsin kinase (RHOK) act together in
the recovery phase of RHO. After photoactivation, RHOK
phosphorylates photoexited RHO which is then blocked
by SAG binding thus inhibiting its ability to interact with
transducin [19,20]. The existence of stable complexes be-
tween RHO and its regulatory protein SAG were demon-
strated to be responsible for retinal degeneration in
several mutations in Drosophila [21]. Accumulation of
these complexes triggers apoptotic cell death showing that
retinal degeneration requires the endocytic machinery
(op. cit.). Interestingly, loss of function in the SAG gene
causes ar inherited Oguchi disease in Japanese, a variant
of congenital stationary night blindness [22,23]. Appar-
ently the mutation causing Oguchi disease can also lead to
arRP in Japanese families [24]. Here we report on the
identification of intronic sequences and mutation screen-
ing of the canine photoreceptor-specific SAG gene in 19
different dog breeds.
Table 2: Primers for the characterization of the SAG gene
Exon Forward primer,
 reverse primer (5'–3')
Exon (#)
and size (bp)
Intron
size (bp)
splice donor site (gt),
splice acceptor site (ag)
1–2 GGGCAACCCTGTCCAGG (1) 156 836
ACACCCTGGGGTCTGTGTC CACAAGgtacatg
2–3 AGTGAAAGAAGCTACCAGGGA (2) 132 ~ 5500 ttcccagCTTGCT
ACCCACAGGCTCTACTTGT AAGTCGgtaagtgg
3–4 AGGTGACCATCTACTTGGG (3) 61 ~ 2600 cctatagGTGACC
AAAGTTCTTTCCTAGCACTAAGa CTGTGGgtaagttg
4–5 AGATGGTATCGTGTTGGTGG (4) 45 ~ 1800 ggtttagATGGTA
ACCGTGAGCAGGAAGGG AGAAAGgtaagaca
5–6 AGTGTATGTCTCTCTGACCTG (5) 194 ~ 2000 cctccagTGTATGT
ACCTTCCCCATGTCTTGCG CTCACGgtgggtg
6–7 CAAGTTTTACACACTGAGTGCa (6) 60 ~ 1300 cccacagTTCCCTG
TCGCAGGCCACAGAGGAGAAGa GGGAAGgttagtg
7–8 GTGCTGTGGGGTCGACTTT (7) 77 ~ 1500 actgcagTGCTGTG
CAGCACCCACAGCAGATTGa CAAGAAgtaagagt
8–9 AGGAGGTCCGTGCGTTTTAC (8) 136 905 tctgcagGAGCTCC
CTAATGCCTTTAATCTTCTTC AAAGAGgtgagcca
9–10 CCTAGAAAGCCATGAGATTAAAa (9) 85 ~ 1500 ttttcagATCTATT
AAGCCAAGCATCCTACTTCC CATTAGgtaggaac
10–11 TGGAACAAGTGGCCAACGTTa (10) 73 ~ 2500 tctgcagTGGAACA
ACATGGTGCTGCAAGG AACACAgtgagtag
11–12 GGACTGATGGTGGCTTTATGa (11) 138 ~ 3200 cctacagAGAAAAA
ACCCTGACACCGTGAGCTTC CACCATgtgagtcc
12–13 TGAGGGATGTGTTCATCTAGa (12) 78 1390 tgagcagAATAAAG
TTCATAACACCTCTGAGCTACa GTCAGGgtgagtgt
13–14 CTGGAGGTGAGCTCTCCCA (13) 24 ~ 1400 ttcctagCTTTCTG
GTGCTCAGGGACCACTAG CTCCAGgtaagcct
14–15 AGTGAAGTGGCAACTGAGGT (14) 56 ~ 3000 tttccagTGAAGTG
AAGCCGAAGACTGGGAGCa ACCCAGgtcagtcg
15–16 CCTGCTCACGATTCTCTTTC (15) 16 426 cttacagCTACGGC
GTCCAGGTCGACCGACCT GGAAAGgtgagccc
(16) 237 tcttttagTTTTCA
PCR amplification of the canine SAG gene: primers for the identification of exon/intron boundaries and for the determination of intronic lengths of 
the canine genomic SAG clones (exon sequences are shown in upper case) athe intronic sequences of the SAG gene received the EMBL accessions 
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Results and Discussion
Genomic organization of the SAG gene
The screening of the canine genomic library with probes
for exons 2, 5 and 16 led to the isolation of seven DNA
clones, each containing different parts of the SAG gene.
This gene contains 16 exons with the 5'UTR split into ex-
ons 1 (156 bp) and in 2 (57 bp). The 3'UTR is comprised
in exon 16 (137 bp). The coding region is 1215 bp long.
Most introns were longer than 1.5 kb (Table 2). Com-
pared to the human SAG gene the position of intron 1,
which is in the 5'UTR, is 23 bp further upstream in the
dog. This means the canine exon 1 is 23 bp shorter and
exon 2 23 bp longer than the equivalent human exons. In
dogs exon 15 is 6 bp longer and exon 16 6 bp shorter than
the equivalent exons in human. Therefore, the predicted
protein in both species are 405 aa long and have a similar-
ity of 89.8%. The intron sizes in man and dog differ, lead-
ing to gene sizes of ~ 35 kb in dog and ~ 40 kb in man.
The splice donor and acceptor sites follow the GT/AG rule
(Table 2). Canoidea-specific, tRNA-derived short inter-
spersed nucleotide elements (SINE; [25]) were identified
in introns 1, 3 and 14 and additional repetitive elements
in introns 2, 3 and 14. The human SAG gene maps to
chromosome 2q37.1. On the basis of reciprocal chromo-
some painting [26], the canine gene is, therefore, predict-
ed to map to CFA 28 or 33, the homologous
chromosomal regions in dogs.
Mutation screening by PCR-SSCP analysis
The SAG gene was screened for mutations in 23 breeds, in-
cluding all gPRA-affected, selected healthy dogs as well as
obligatory carriers. The 16 exons were analysed by PCR-
SSCP including all intronic splice signal sequences as well
as the UTRs (i.e. complete cDNA plus >3070 bp of the in-
trons). In the coding region of the SAG gene, 5 polymor-
phisms were identified that result in altered amino acid
coding (H14C, A111V, A113T, D259T and A379E), and 7
silent polymorphisms were identified (C132C, Q199Q,
H225H, V247V, P264P, T288T and L293L; Table 4). In ad-
dition, 13 sequence variations were identified in 9 introns
of gPRA affected and unaffected animals (Table 4). Several
gPRA-affected dogs in 14 of the 23 breeds were hetero-
zygous for one of the aforementioned polymorphisms
(Table 4). In 6 of these 14 dog breeds the major cause of
gPRA has meanwhile been determined. Direct DNA tests
are possible for Irish Setters and Sloughis [8,9]. Indirect
tests for progressive rod cone degeneration (prcd) were re-
cently offered for Australian cattle dogs, English Cocker
Spaniels, Labrador Retrievers and Miniature poodles (pat-
ented by OptiGen, USA). These dog breeds were included
as controls to characterise the identified polymorphisms
to exclude linkage for causal gPRA mutations. A second
gPRA form may be exist in Irish Setter because one affect-
ed Setter shows a late form of gPRA without the typical
PDE6B mutation. Because of the clinical signs, also in
Miniature poodles two types of gPRA are possible (Opti-
Gen).
Conclusions
None of the amino acid changes identified here in dogs
correspond to residues that are mutated in known RP, nor
are they known to be important for binding activated de-
phosphorylated RHO [22,23,27]. As detailed above,
Oguchi disease and some forms of arRP is caused by the
deletion in codon 309 in Japanese. None of the aa ex-
changes in the dog breeds investigated here correspond
with this region. Nevertheless, these novel sequence vari-
ations can be used as intragenic markers for segregation
analyses with ar gPRA. The breeding history, small popu-
lation sizes and gPRA abundance in the investigated
breeds point together to few meiotic events in which intra-
genic recombinations could have occured between an un-
identified mutation in the SAG locus in gPRA dogs and
the polymorphisms investigated here. Given ar transmis-
sion our typing results suggest that the sequence varia-
tions in the SAG gene are not causative for gPRA in the
following 14 dog breeds: AC, BDP, Bo, BS, ECS, D, IRS,
GR, MP, NF, PON, Sa, SD and Sl. In 6 of these dog breeds
only one gPRA affected animal was available for mutation
analysis (Table 1). For these breeds the exclusion of theS-
AG gene is not definitive, since the possibility of false di-
agnosis is not ruled out completely. Nevertheless, gPRA-
affected AW, CCR, SP, LR, Ro and TT show homozygous
sequence variation patterns and 3 dog breeds (Co, EM,
GS) did not harbour any sequence variations. Therefore,
the SAG gene cannot be excluded as a cause for gPRA in
these breeds, especially because of mutations in the elu-
sive regulatory regions for gene expression.
Materials and Methods
Animals
Blood from 810 dogs of 23 different breeds, including 113
gPRA-affected animals (Table 1) was collected with the
permission of the owners and in cooperation with breed-
ing organisations. Experienced veterinarians confirmed
the gPRA status of healthy and affected dogs by ophthal-
moscopy.
Isolation of canine DNA and PCR
DNA was extracted from peripheral blood according to
standard protocols [28]. Portions of the SAG gene were
amplified by PCR in a thermocycler (Biometra, Goettin-
gen, Germany) from the inserts of the λ  phages in order to
obtain intronic sequences. Genomic DNAs from all gPRA-
affected, obligate carrier and gPRA-unaffected dogs were
screened for sequence variations. PCRs were performed in
96-well microtiter plates (Thermowell Costar Corning,
NY). Each well contained 50 ng DNA in 10 µl reaction vol-
ume (100 mM Tris [pH 8.3], 500 mM KCl, 1 U Taq
Polymerase [Genecraft, Münster, Germany], 0.2 mmol ofBMC Genetics 2002, 3 http://www.biomedcentral.com/1471-2156/3/12
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each NTP, 0.4 mM of each primer and varying concentra-
tions of MgCl2 [Table 3]). For SSCP analysis, 0.06 µl of
[α 32P] dCTP (10 mCi/ml) was included in the PCR. Parts
of the λ  phage inserts were amplified in a one step PCR
(annealing temperatures in Table 3). For genomic muta-
tion analysis PCR conditions included initial denatura-
tion (5 min at 95°C), the 10 initial cycles 1°C above the
annealing temperature (Table 3), 22–25 cycles of 95°C
(30 s), annealing temperature (30 s), elongation at 72°C
(40 s) and a final elongation step at 72°C (3 min).
Cloning and identification of exon/intron junctions
Clones containing the SAG gene were isolated from a ge-
nomic canine λ -DNA library (λ  FIX®II Library; host: E. coli
XL1-Blu MRA (P2) Stratagene, La Jolla, Ca, USA) accord-
ing the manufacturer's protocol. Recombinant λ  DNA was
fixed to Hybond™-N Nylon membranes (Amersham,
Buckinghamshire, UK) and UV-crosslinked (1' 70 J/cm2).
The library was screened with probes prepared from PCR
products corresponding to portions of exons 2, 5 and 16
(nucleotides 909–1157 of EMBL accession number
CFA426068, nucleotides 395–588, and 1333–1579 of
EMBL accession number X98460, respectively). These
probes were labelled using [α 32P] dATP and the Meg-
aprime Labelling System (Amersham, Buckinghamshire,
UK). Hybridisations were performed at 65°C in 0.5 M so-
dium phosphate buffer (pH 7.2)/7% sodium dodecyl sul-
fate [29]. After hybridisation the filters were washed twice
for 30 min each in 2×  SSC/1% SDS, once for 15 min with
0.2×  SSC/1%SDS at 65°C and for 30 min with 6× SSC at
Table 3: Primer sequences used for mutation analysis of individual exons/introns of the canine SAG gene
Primer Location Forward primer, reverse primer (5'–
3')a
PCR conditions 
[T-°C/MgCl2-
mM]
PCR amplicon 
length (bp)
Restriction 
enzymes for 
SSCP analyses
UTR1F exon 1 GGGCAACCCTGTCCAGGT 54/1.0 699 NlaIII/RsaI
UTRI-1aR intron 1 TCTATCATGACGGGACGCCT
UTRI-1aF intron 1 GAAAATGATATTTGCAAAGCAG 50/1.0b 283 Tru1I
UTRI-1aR intron 1 TCTATCATGACGGGACGCCT
1-IF intron 1 CTAATGGGCACACAGCATCTC 53/1.0 249 PvuIII; NlaIIIc
2-I2R intron 2 TTCTGTTAAGCCACTCACTTC
3-IF intron 2 TGTTTTTATCTAACACTGACTACTTC 48/1.0b 224 NlaIII
3-IR intron 3 AAATAACAAAGTAGCAGCTGTC
4-IF intron 3 AACTGCAGATAAATATATGAAG 52/1.0 189 AluI
4-IR intron 4 AAAGTTCTTTCCTAGCACTAAG
5-IF intron 4 GGTTACCCCATGTTCACTTG 56/1.0 343 MnlI
5-IR intron 5 GCTCCTGGTCACACTGCAAG
6-IF intron 5 CAAGTTTTACACACTGAGTGC 55/1.0 213 AluI
6-IR intron 6 ATTTTCCCCAGAGAAAAGGCTA
7-IF intron 6 CGGGAAGGGAGGTGCTGA 58/1.0 233 RsaIc
7-IR intron 7 TCGCAGGCCACAGAGGAGAAG
8-IF intron 7 ATCACAGCGTGAGTACGGGGAG 55/1.0 288 RsaI; PstIc
8-IR intron 8 CAGCACCCACAGCAGATTG
9-IF intron 8 CCTAGAAAGCCATGAGATTAA 55/1.5 214 TruI1; StyIc
9-IR intron 9 GACCAGACTGAGAAATTCTAG
10-IF intron 9 GGCACCATGCACATGCGTG 58/1.0 235 AluI
10-IR intron 10 AAGCCAAGCATCCTACTTCC
11-IF intron 10 GGACTGATGGTGGCTTTATG 58/1.0 266 BsuRI
11-IR intron 11 AGCAGACCAGCACCTCCTC
12-IF intron 11 TGAGGGATGTGTTCATCTAG 55/1.0 183 -
12-IR intron 12 GCCCATGGTGTTGGCTCTTG
13-IF intron 12 CATGCTTGGGACATGTCCAC 64/1.0 209 MvaI
13-IR intron 13 TTCATAACACCTCTGAGCTAC
14-IF intron 13 CTCTGCAGCCACAGCCCTTC 50/2.0 229 AvaII
14-IR intron 14 GTGCTCAGGGACCACTAG
15-IF intron 14 CCTGCTCACGATTCTCTTTC 58/1.0 244 HphI
15-IR intron 15 AAGCCGAAGACTGGGAGC
16-IF intron 15 GATCGGTCCCTTGTTGCA 52/2.0b 347 AluI
16-ER Exon 16 CACAGCTGAACAGACAAACTT
aSee EMBL accession numbers AJ426068-AJ426078 bwith 5% formamide cwith RLFP analysisBMC Genetics 2002, 3 http://www.biomedcentral.com/1471-2156/3/12
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room temperature. The filters were exposed to phos-
phoimager screens (STORM 860) and evaluated with the
programs STORM Scanner Control and Image Quant
(Molecular Dynamics). Hybridising clones were isolated
and plaque purified as described [30]. The approximate
insert sizes of the different clones were estimated with
exon primers via PCR (see conditions described above us-
ing~0.2 ng phage DNA, 2 mM MgCl2 and annealing tem-
perature of 54°C in the PCR).
Exon/intron boundaries were analysed by comparison of
canine mRNA ([17], EMBL accession number X98460)
with 16 genomic sequences of the human SAG gene (5'-
flanking region and exon 1 [18]; EMBL accession number
X12453); exons 2–16 ([31]; EMBL accession numbers
U70963-U70976) using the program Blast Search (NCBI
[http://www.ncbi.nlm.nih.gov/blast]). Intronic sizes were
estimated by overlapping PCR including parts of neigh-
bouring exons. PCR products were extracted from 1.5%
agarose gels using the Easy Pure extraction kit (Biozym,
Germany) and sequenced with intron-overlapping prim-
ers (Table 2). Sequencing reactions from 2–3 clones were
carried out by the dideoxy-chain termination method us-
ing the BDT (Perkin-Elmer, Norwalk, CT) according to the
manufacturer's instructions. All sequencing reactions
were run on an automated DNA sequencer (Applied Bio-
systems 373 XL, Foster City, USA) and analysed using ABI
Prism™ 373XL.
PCR-SSCP and DNA sequence analysis
Positions of intronic primers which were used for muta-
tion screening were selected after DNA sequence analysis
of the genomic SAG clones (Table 3). SSCP samples were
treated as previously described [16,32]. PCR products
were digested dependent on the lengths of the fragments
[33] with different restriction enzymes (Table 3). Using re-
striction length fragment polymorphism (RLFP) analysis
the sequence variants in exon 2 (NlaIII), intron 7 (RsaI),
Table 4: SAG sequence variations and amino acid exchanges in respective dog breeds
Sequence variations in breed(s)a
Location Sequence variation* Amino acid exchange In affected and gPRA unaffected dogs gPRA affected dogs in heterozygous state
Intron 1 IVS1+393T→ C- B D P ,  B S ,  G R ,  I R S ,  R o b, TT BDP, GR,
Exon 2 UTR-5A→ G - Bo, BS, GRc, BDP, IRS, SDc, Sl, TTb Bo, GR, SD
c255A→ G H14C SI Sl
Exon 5 c526C→ T A111V Sac Sa
c531G→ A A113T Sac Sa
Intron 5 IVS5-30C→ T- E C S ,  M P ,  R o b, Sac ECS, MP, Sa
Exon 6 c610C→ T C132C GR GR
Intron 7 IVS7+10C→ T- I R S b, GR, SPc D, IRS, GR
IVS7+52Ins.G - GRc GR
IVS7-4Del.G - CCRb D, GR, IRS, MP, SDc, Slc, SPb, TTc D, GR, IRS, SD
Exon 8 c811G→ A Q199Q GR GR
Intron 8 IVS8+8A→ G - D, ECSc, GRc, LRc, Sa D, ECS, GR, Sa
Exon 9 c874T→ C H225H Bo, BDP, CCRb, ECS, D, GRc, IRS, MP, 
NF, Rob, Sa, Slb, TTbc
Bo, ECS, D, GR, IRS, MP, NF, Sa
Exon 10 c949G→ T V247V IRS, GR GR
c983G→ T D259T ACb AC
c1000A→ G P264P AC, LR, IRSb, GR GR
Intron 10 IVS10-18G→ C- G R ,  I R S ,  B D P G R
IVS10-33C→ T- G R ,  I R S G R
Exon 11 c1063G→ A T288T BS, BDP, GR, IRSb, Sa BS, GR, Sa
c1076C→ T L293L BS, BDP, GRc, Sa, TT BS, Sa
Intron 11 IVS11-51Ins.TT - Sa, IRSb Sa
Intron 13 IVS13+66C→ G- S a ,  I R S b Sa
Intron 14 IVS14-45Del.A - PON PON
Intron 15 IVS15+14C→ T- S a -
IVS15+86T→ A- S a -
IVS15-45Ins.C - PON, AWbc, SPb PON
Exon 16 c1344C→ A A379E IRSb, ECSb, GRc, PON, Sabc, TTb ECS, GR
a For abbreviations see Table 1b Homozygous state in gPRA affected dogs c Homozygous state in unaffected dogs *(EMBL accession number for 
cDNA: X98460; EMBL accession numbers for genomic DNA: AJ426068-AJ426078)BMC Genetics 2002, 3 http://www.biomedcentral.com/1471-2156/3/12
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exon 8 (PstI) and exon 9 (StyI) were investigated. 3 µl of
the PCRs were denatured with 7 µl of loading buffer (95%
deionised formamide 10 mM NaOH, 20 mM EDTA,
0.06% (w/v) xylene cyanol, and 0.06% (w/v) bromophe-
nol blue). The samples were heated to 95°C for 5 min and
snap cooled on ice. 3 µl aliquots of the single-stranded
fragments were separated in 2 sets of 6% polyacrylamide
(acrylamide/bisacrylamide: 19/1) gels, one set containing
10% glycerol, another containing 5% glycerol and 1 M
urea. Gels were run with 1×  TBE buffer at 50–55 W for 4–
6 h at 4°C. All gels were dried and subjected to autoradi-
ography over night. Selected DNA samples with band
shifts evidenced by SSCP electrophoresis were purified
and cycle sequenced as described above.
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